FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT)

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / NY ARCA BIOTECH
Number of holders
10
Total 13F shares, excl. options
40,813
Shares change
+82
Total reported value, excl. options
$8,437,633
Value change
+$16,936
Number of buys
2
Number of sells
3
Price
$206.52

Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q4 2025

As of 31 Dec 2025 FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 40,813 shares of stock of the company.
Largest 10 holders included Holistic Financial Partners, Davis Investment Partners, LLC, GoalVest Advisory LLC, PARK AVENUE SECURITIES LLC, LAKE STREET PRIVATE WEALTH, LLC, WealthCare Investment Partners, LLC, RDA Financial Network, PUFF WEALTH MANAGEMENT, LLC, HARBOR INVESTMENT ADVISORY, LLC, and GAMMA Investing LLC.
This table shows 10 institutional shareholders of the security as of 31 Dec 2025.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.